Erik Blomquist
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Intravoxel incoherent motion imaging and dynamic susceptibility contrast perfusion MRI in differentiation between recurrent intracranial tumor and treatment-induced changes.
Journal: Neuroradiology
Published: January 25, 2024
Magnetic resonance imaging detected radiation-induced changes in patients with proton radiation-treated arteriovenous malformations.
Journal: Acta radiologica open
Published: August 23, 2021
Dynamic contrast-enhanced magnetic resonance imaging may act as a biomarker for vascular damage in normal appearing brain tissue after radiotherapy in patients with glioblastoma.
Journal: Acta radiologica open
Published: August 26, 2018
Perfusion Magnetic Resonance Imaging Changes in Normal Appearing Brain Tissue after Radiotherapy in Glioblastoma Patients may Confound Longitudinal Evaluation of Treatment Response.
Journal: Radiology and oncology
Published: January 17, 2018
Long-term evaluation of the effect of hypofractionated high-energy proton treatment of benign meningiomas by means of (11)C-L-methionine positron emission tomography.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 24, 2015
Positive correlation between occlusion rate and nidus size of proton beam treated brain arteriovenous malformations (AVMs).
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 15, 2015
PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 16, 2013
Vandetanib combined with a p38 MAPK inhibitor synergistically reduces glioblastoma cell survival.
Journal: Medical oncology (Northwood, London, England)
Published: May 29, 2013
Considerable improvement in survival for patients aged 60-84 years with high grade malignant gliomas -- data from the Swedish Brain Tumour Population-based Registry.
Journal: Acta oncologica (Stockholm, Sweden)
Published: February 13, 2013
Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
Journal: Cancer chemotherapy and pharmacology
Published: January 09, 2013
A review of dose-dense temozolomide alone and in combination with bevacizumab in patients with first relapse of glioblastoma.
Journal: Anticancer research
Published: September 21, 2012
Last Updated: 09/26/2026